technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cystic Angiomatosis Of Bone, Diffuse in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De La Cueva, L; Liévano, P; López Vélez, L; Navarro, P; Rodríguez Chacón, L; Sanz Moncasi, P | 1 |
Endo, K; Hosono, M; Kobayashi, H; Konishi, J; Sakahara, H; Shigeno, C; Yao, ZS | 1 |
2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cystic Angiomatosis Of Bone, Diffuse
Article | Year |
---|---|
Gorham's disease: 99mTc HMDP bone scan findings.
Topics: Biopsy; Bone Density Conservation Agents; Bone Neoplasms; Calcinosis; Calcium; Diagnosis, Differential; Diphosphonates; Drug Therapy, Combination; Edema; Humans; Humerus; Imidazoles; Male; Middle Aged; Multimodal Imaging; Osteolysis, Essential; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Scapula; Shoulder Joint; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid | 2012 |
Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Topics: Adult; Bone Neoplasms; Hemangioma; Humans; Male; Organotechnetium Compounds; Osteolysis, Essential; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Medronate | 1994 |